Pathological changes of the myocardium in reworsening of anthracycline-induced cardiomyopathy after explant of a left ventricular assist device
Hiroaki Hiraiwa, Takahiro Okumura, Shinya Shimizu, et. al.
Nagoya J Med Sci. 2020 Feb;82(1):129-134. doi: 10.18999/nagjms.82.1.129.J
CARDIONCOLOGY.ORG ABSTRACT:
This article presents the case study of a 42-year-old patient with worsening anthracycline-induced cardiomyopathy after explantation of a left ventricular assist device (LVAD).
The authors concluded that although the patient had received optimal medical therapy for heart failure and had maintained a healthy lifestyle after temporary recovery of left ventricular ejection factor, his cardiac function nevertheless worsened enough to consider the possibility of again require LVAD in the future.
© All Rights Reserved